Tracon Pharmaceuticals Inc (TCON) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access TCON Annual Balance Sheets →
Balance sheet data covering Tracon Pharmaceuticals Inc–Jun 30 2023 offers a view into how Jun 30 2024's financial position has changed alongside business activity.
Quarterly Report, GAAP in USD millions
ITEM
(Jun 30 2024)
(Mar 31 2024) (Dec 31 2023) (Sep 30 2023) (Jun 30 2023)
Assets
Cash & cash equivalent6.27
Cash & Short-term Investments6.00
Other Current Assets0.00
Prepaid Expense And Other Assets Current0.24
Total Current Assets6.51
Equipment/Property/Plant Net0.03
Other Assets, Noncurrent0.86
Collaboration Receivable Current-
Restricted Cash Noncurrent0.07
Total Assets7.40
Liabilities
Accounts Payable, Current AC2.65
Accrued Liabilities, Current7.24
Other Liabilities, Current0.00
Total Current Liabilities9.89
Total Long-term Debt0.00
Accounts Payable And Accrued Expenses Excluding Compensation And Related Expenses-
Total Liabilities10.49
Stockholders' Equity
Common Stock Value0.00
Additional Paid In Capital Common Stock243.41
Retained Earnings / Accumulated Deficit-246.51
Other Equity0.00
Common Stockholder's Equity-3.09
Total Stockholder's Equity-3.09
Liabilities & Stockholder's Equity7.40
4 historic quarters locked

Sign in to unlock the full Tracon Pharmaceuticals Inc balance sheet history.

About Tracon Pharmaceuticals Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0000950170-24-096403

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.